Targeting how breast cancer cells survive after they detach

Mitophagy-Mediated Cell Death in Mammary Tumorigenesis

['FUNDING_R01'] · UNIVERSITY OF NOTRE DAME · NIH-11210492

This work looks at ways to make detached breast cancer cells die so fewer people with breast cancer develop metastasis.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF NOTRE DAME (nih funded)
Locations1 site (NOTRE DAME, UNITED STATES)
Trial IDNIH-11210492 on ClinicalTrials.gov

What this research studies

The team is studying what happens when breast cancer cells lose contact with their surroundings and begin to spread. In lab-grown 3-D cell models and in mice, researchers will track damaging molecules called reactive oxygen species (ROS) and a recycling process in cells called mitophagy. They will test which pathways help detached cancer cells survive and try interventions that push those cells toward death. The goal is to find molecular targets that could be used to develop drugs to stop early metastatic cells.

Who could benefit from this research

Good fit: People with breast cancer, particularly those at higher risk of metastasis or whose tumors show features linked to cell detachment, would be the most relevant population for future clinical work based on this research.

Not a fit: People without breast cancer or those with low-risk localized disease are unlikely to get direct benefit from this laboratory-focused work in the near term.

Why it matters

Potential benefit: If successful, this could reveal new targets for therapies that selectively kill metastatic or circulating breast cancer cells before they form new tumors.

How similar studies have performed: Prior laboratory studies have shown that changing ROS levels and cell-death pathways can kill cancer cells in models, but turning those findings into proven human treatments remains mostly unproven.

Where this research is happening

NOTRE DAME, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Breast Cancer Cell

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.